Another Life: Our second ash comes into conflict with technology – The Irish Times

I could have looked up when kneeling to plant the little ash tree some 30-odd years ago. Then I might have considered the powerline high above me, strung from the transformer beyond the hedge to the pole beside the house.

But perhaps I just couldnt imagine the ambition locked up in the sapling I was firming in.

This summer, as the trees topmost twigs reached up to embrace the wire, I began to dread the approach of early autumn storms. It was time to consult the ESB.

Theyre jolly decent in these matters. If the offending tree is beyond the immediate domestic pole, they will, in good time, despatch a remedial team with a baby chainsaw on a very long pole.

This was, sadly, our second ash to come into conflict with technology. A tree planted closer to the house grew into a strong-muscled, shapely candelabra, beautiful in every season. But it came to obstruct the wireless beams by which we shared our broadband with neighbours. Its pollarding prompted final felling, to our mutual regret.

Meanwhile, the wayside ashes of the west stand as defiantly healthy emblems of their kind. Further east, and across the midlands, hedgerow ashes and forest plantations have been scarred by the single most devastating forest pathogen ever to hit the postglacial woodlands of Ireland. That was Teagascs blunt summation of Chalara ash dieback, wrought by the Asian fungus Hymenoscyphus fraxineus.

Since its first discovery in Co Leitrim in 2012, its airborne spores have had worst impact on young ash plantations, their leaves wilting and blackening into death. It is now established in all counties in Ireland, but as yet spares large reaches of the western seaboard, saved by Atlantic winds.

In 2013, the Department of Agriculture, Food and the Marine devised a reconstitution scheme to help in clearing affected plantations and planting them with alternative species. By 2018, this had cost some 5.8 million, for more than 1,000 hectares, but it stopped when scientists advised that eradication of ash dieback was no longer feasible.

After widespread damage throughout Europe, the research priority is finding the small minority of ash trees that are tolerant of the disease, passing on their tolerance genetically.

Actual resistance to the fungus has not been found in any common ash population. And even naturally tolerant trees, left to themselves, could take many decades or even centuries to evolve any widespread, rural equilibrium.

Thus, say geneticists working with Irelands Council for Forest Research and Development (Coford), the focus is on breeding from tolerant trees and spreading their progeny to forests and hedgerows over a much shorter time.

Even to identify tolerant trees needs an environment where the pressure of disease is high and their stubborn health quite evident. This is still unusual in Ireland, so most of the breeding programmes are in Europe.

However, Teagascs forestry researchers have had access to ash trees of widely varied Irish provenance already growing in six countries and planted for an earlier, unrelated trial. They include 1,000 trees in Lithuania and 14,000 in the UK. Using such material from Belgium ,they have identified chemicals in the ash that distinguish tolerant trees from those sensitive to dieback.

Two bark chemicals most strongly associated with tolerance belong to the family of coumarins, their sweet scent familiar from freshly mown hay. Such molecular signals are now helping to seek out tolerant trees in Irish stands.

Dr Gerry Douglas, just retired from Teagascs breeding ash research, puts such trees at 1 to 2 per cent. The best news, he says, is that this natural resistance in ash is heritable, and also highly stable in trees that are propagated vegetatively.

This is different, as he points out, from the restorative breeding of disease-resistant elms, which involves introduction of new genes from Asian elm species.

The ash-breeding programme will need large nurseries to propagate trees by grafting and for production of cuttings for rooting. A second stage begins with producing small amounts of seed from grafted trees grown in high polytunnels.

This needs controlled pollination of mother tree flowers from tolerant father trees. Later, more seed can come from orchards of tolerant trees grown from grafts and rooted cuttings.

All this will take years, as Coford sets it out, perhaps as long as 20. But Gerry Douglas is confident that the programme will produce resistant ash seed for sprinkling along the hedgerows.

Go here to read the rest:

Another Life: Our second ash comes into conflict with technology - The Irish Times

Bodle Technologies announces world’s first TFT driven Solid State Reflective Display fabricated on a GEN2.5 line – Digital Signage Connection

Bodles Taiwan Team Albert Tsai, TS Jen and Luc Lai with the SRD prototype panel at Taiwans ITRI

Oxford UK, 7 August 2020.Bodle Technologies Ltd has developed the worlds first TFT driven Solid State Reflective Display (SRD) fabricated on a GEN2.5 line at Taiwans Industrial Technology Research Institute (ITRI).

Led by Bodles VP for Manufacturing, TS Jen, the team in Taiwan transferred the designs and research activities directly from the Oxford based team to produce the test displays.

TS Jen comments: This is an important milestone for Bodle, giving us the confidence that our technology is manufacturable using standard processes. We are delighted to be doing this in an ecosystem where many new display technologies have been launched.

The SRD is an ultra-low power, colour reflective display, based on phase-change materials, which work over a wide range of temperatures. They have applications in areas such as mobile second screens, electronic shelf edge displays as well as personalized jewellery and watches.

New VP of Materials and Engineering, Andrew Pauza adds: To see this technology being scaled from a few pixels on R&D samples made on a lab coater to work on displays with nearly a quarter of a million pixels, made on a production coater is fantastic. Many of the materials and production processes are based on those used for rewritable optical disc, an area where I have worked for many years. We have been able to apply these processes to accelerate this move to a more manufacturable process for the SRD.

This step forward provides further impetus to the companys expansion and scale up plans within Taiwan as it looks to commercialise its technology within the coming years.

###

Picture caption:Bodles Taiwan Team Albert Tsai, TS Jen and Luc Lai with the SRD prototype panel at Taiwans ITRI

About Bodle Technologies Ltd

Bodle Technologies is developing SRD, the worlds first solid-state reflective display technology, based on phase-change materials. Providing vivid colour and video-capability, with zero energy use for static image storage, the technology is ideally suited to address the issues of poor outdoor readability and high power consumption associated with transmissive and emissive displays.

Invented at the University of Oxford, the science behind SRD was first published in Nature during 2014.

Bodle was founded the following year and has a growing IP portfolio covering this new display technology. Bodles investors are led by Oxford Sciences Innovation (OSI)

http://www.bodletechnologies.com

Read more:

Bodle Technologies announces world's first TFT driven Solid State Reflective Display fabricated on a GEN2.5 line - Digital Signage Connection

Color Star Technology Announces Machine Gun Kelly will join its "Fearless, Color World" Online Concert – PRNewswire

NEW YORK, Aug. 7, 2020 /PRNewswire/ -- Color Star Technology Co., Ltd. (Nasdaq CM: HHT) (the "Company"," we", or "HHT") is pleased to announce that American rapper, singer, songwriter and actor Machine Gun Kelly will join the Color World app owned by the company for its online concert "Fearless, Color World" on September 9th. As one of the leading talents in global pop music, alternative, and hip hop, he is sure to bring fans of all background a moment to be remembered.

"Fearless, Color World" online concert is a new type of concert launched by Color Star Technology which provides innovative art Training Service. The concert has invited many world-class artists to perform, hoping to make the audience feel the peace of the world, and the eternal love.

Machine Gun Kelly is an American well-known rapper, he embarked on a musical career as a teenager, releasing a mixtape in 2006. After he joined Interscope Records which is owned by Universal Music Group, his first major label debut album "Lace Up" reached number 4 on the Billboard 200 chart and sold more than 178,000 copies. In addition, his singles "Till I die" and "A little More" for his second studio album debuted at number four in the US, and "Bad Things" in his third studio album "Bloom" peaked number 4 on the Billboard Hot 100.In addition to his music career, he has acted in a number of Americanfilms.

Biao (Luke) Lu, CEO says "We are thrilled to partner with Machine Gun Kelly in the planned concert, a live event featuring colorful music, colorful life, and a colorful world. With warmth and hope, we celebrate our own lives and the hopes of the world. The performance brought by Machine Gun Kelly will channel through the Color World platform to reach hundreds of millions of potential audiences around the world. With dazzling stage design and top audio equipment, we believe that this online concert will definitely bring our platform users a brand-new online concert experience."

About Color Star Technology Co., Ltd.

Color Star Technology Co, Ltd. (Nasdaq: HHT) offers online and offline innovative education services for music and entertainment industries globally. Its business operations are conducted through its wholly-owned subsidiaries Color China Entertainment Ltd. and CACM Group NY, Inc. The Company's online education is provided through its Color World music and entertainment education platform. The Company also offers after-school entertainment tutoring inNew Yorkvia its joint venture entity Baytao LLC.

Machine Gun Kelly Biography

Colson Baker, also known as "Machine Gun Kelly," is a multi-hyphenate talent with an impressive career that started in Cleveland and has made him a globally known star in both music and film.

As Machine Gun Kelly, he burst onto the music scene with therelease of his first albumLace Upvia EST 19XX/Bad Boy/Interscope Records. The album debuted at number two on Billboard's R&B/Hip-Hop Albums chart. He won "US Artist About to Go Global" at the 2012 MTV EMA's and MTV's 2012 "Breaking Woodie" Award. The following year he was awarded "Woodie of the Year" beating out A$AP Rocky, Fun, Grimes and Kendrick Lamar. His 2015 sophomore album,General Admissionclinched a #1 spot on Billboard's R&B/Hip-Hop Album charts. He's performed on THE VOICE, THE TONIGHT SHOW WITH JIMMY FALLON, THE LATE LATE SHOW WITH JAMES CORDEN, ELLEN, BET's 106 AND PARK, THE NICKELODEON KIDS CHOICE AWARDS and several other programs and award shows. His songs have appeared in soundtracks for the feature films BRIGHT and WHY HIM?.

Spotify recently released that his songs were streamed 571,200,000 times in 79 countries in 2019. His most recent albumHotel Diablowas released July 5, 2019 and was supported by three singles: "Hollywood Whore", "El Diablo", and "I Think I'm Okay" (featuring Travis Barker and Yungblud). "I Think I'm Okay" became a certified Gold Single in December of 2019. In 2017, his albumbloomwent gold. The album track "Bad Things" featuring Camila Cabello, sold 8+ million worldwide, was nominated for a 2017Billboard Music Award and owned the Billboard 100 list for 16+ weeks in 2017. The song has had more than 245m+ streams with a radio audience of 145m, becoming RIAA certified 3x platinum (domestic) and 8x worldwide. "Machine Gun Kelly" was one of the top ten most searched artists of 2018 according to Google. In April 2020, he released "Bloody Valentine," the first single off his forthcomingTickets to My Downfall album, executive produced by Travis Barker. The two appeared on THE LATE LATE SHOW WITH JAMES CORDEN to perform the song, and the official video starring Megan Fox garnered over 4,000,000 views in under 24 hours.

On the acting side, he received critical acclaim as thelead role as Tommy Lee in the Netflix'sTHE DIRT, a biopic based on the rise of the band Motley Crue directed by Jeff Tremaine. He also starred opposite Sandra Bullock, John Malkovich and Trevante Rhodes in Netflix's thriller film BIRD BOX. In its first week of streaming, 45,037,125 Netflix accounts watched the film, making it Netflix's most streamed film at the time. He appeared in BIG TIME ADOLESCENCE from writer/director Jason Orley, also starring Pete Davidson, Griffin Gluck and Jon Cryer, which premiered in competition at the 2019 Sundance Film Festival and wasreleasedby NEONon Hulu inMarch 2020. He will next be seen in Netflix's PROJECT POWER from Henry Joost and Ariel Shulman also starring Jamie Foxx and Joseph Gordon-Levitt which will premiere globally inAugust 14, 2020.

Previously, Baker starred on Cameron Crowe's Showtime series ROADIES, playing Wes, a recently fired Pearl Jam roadie who joins his twin sister Kelly Ann (Imogen Poots) on tour for the fictitious Staton-House Band. The series also starred Luke Wilson and Carla Gugino and was executive produced by Cameron Crowe, JJ Abrams, Winnie Holzman and Bryan Burk.

He appeared alongside Dave Franco and Emma Roberts in the Henry Joost/Ariel Shulman Lionsgate film NERVE, opposite Gugu Mbatha-Raw in Gina Prince-Bythewood's BEYOND THE LIGHTS, and in James Merendino's PUNKS DEAD: SLC PUNK 2. Additional films include the Rupert Wyatt directed film CAPTIVE STATE with Ashton Sanders, Vera Farmiga and John Goodman.

At 6'4', the musician/actor has walked in New York Fashion Week, and his distinct look and love for fashion landed him a campaign as the face of John Varvatos for Fall/Winter 2017-2018. Combining his musical talents with the campaign, he played the opening of Varvatos' first ever store in Dubai in November 2018. He also collaborated with Reebok on their Club C sneaker campaign.

When not touring or filming, he resides in Los Angeles.

Forward-Looking Statements

Certain statements made herein are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include the business plans, objectives, expectations and intentions of the parties following the completion of the acquisition, and HHT's estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, our actual results may differ materially from our expectations or projections. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: there is uncertainty due to the COVID-19 pandemic and the impact it will have on HHT's operations, the demand for the HHT's products and services, global supply chains and economic activity in general. These and other risks and uncertainties are detailed in the other public filings with the Securities and Exchange Commission (the "SEC") by HHT. Additional information concerning these and other factors that may impact our expectations and projections will be found in our periodic filings with the SEC, including our Annual Report on Form 20-F for the fiscal year ended June 30, 2019. HHT's SEC filings are available publicly on the SEC's website at http://www.sec.gov. HHT disclaims any obligation to update the forward-looking statements, whether as a result of new information, future events or otherwise.

Color Star Technology Co., Ltd. Contact: Investor Relations FinancialBuzzIR [emailprotected]Tele: +1-877-601-1879

SOURCE Color Star Technology Co., Ltd.

See the rest here:

Color Star Technology Announces Machine Gun Kelly will join its "Fearless, Color World" Online Concert - PRNewswire

5G and Cloud Computing Technologies Market Report, History and Forecast 2020-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application…

The report Global 5G and Cloud Computing Technologies Market offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The main objective of this market research is to help the readers understand the structure of 5G and Cloud Computing Technologies market, market definition, overview, industry opportunities and trends, investment strategy with forceful and reliable data.

To Get The Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-5g-and-cloud-computing-technologies-market-2019-2025?utm_source=thediamondreport&utm_medium=14

Key Players: ADLINK Technology Inc.,Advanced Micro Devices,Advantech,,Akamai Technologies,Allot Communications,Amazon Web Services,Ampla Soluciones SL,AT&T Inc.,Aware360 Ltd.,Broadcom Corporation,Brocade Communications Systems,C3IoT,,Carriots,Cavium Networks,Ceragon Networks,China Mobile,Cisco Systems Inc.

The final report will add the analysis of the Impact of Covid-19 in this report 5G and Cloud Computing Technologies industry.

5G and Cloud Computing Technologies Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. 5G and Cloud Computing Technologies Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

Make an Enquiry @https://www.reportsandmarkets.com/enquiry/global-5g-and-cloud-computing-technologies-market-2019-2025?utm_source=thediamondreport&utm_medium=14

Research objectives:

To study and analyze the global 5G and Cloud Computing Technologies market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of 5G and Cloud Computing Technologies market by identifying its various sub segments.

Focuses on the key global 5G and Cloud Computing Technologies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the 5G and Cloud Computing Technologies with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of 5G and Cloud Computing Technologies submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

Table of Contents: 5G and Cloud Computing Technologies Market

Key questions answered in this report

Browse for Full Report at @: https://www.reportsandmarkets.com/checkout?currency=one_user-USD&report_id=3714989&utm_source=thediamondreport&utm_medium=14

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Go here to see the original:

5G and Cloud Computing Technologies Market Report, History and Forecast 2020-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application...

World TMS (Transcranial Magnetic Stimulation) Coil Market Industry: A Latest Research Report to Share Market Insights and Dynamics – Bulletin Line

The recent research report titled World TMS (Transcranial Magnetic Stimulation) Coil Market Research Report 2025 (Covering USA, Europe, China, Japan, India and etc) has been added in the kandjmarketresearch.com database. The Global TMS (Transcranial Magnetic Stimulation) Coil Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2025.

TMS (Transcranial Magnetic Stimulation) Coil Market Overview

The global TMS (Transcranial Magnetic Stimulation) Coil market has been studied by a set of researchers for a defined forecast period of 2020 to 2025. This study has provided insights to the stakeholders in the market landscape. It includes an in-depth analysis of various aspects of the market. These aspects include an overview section, with market segmentation, regional analysis, and competitive outlook of the global TMS (Transcranial Magnetic Stimulation) Coil industry for the forecast period. All these sections of the report have been analyzed in detail to arrive at accurate and credible conclusion of the future trajectory. This also includes an overview section that mentions the definition, classification, and primary applications of the product/service to provide larger context to the audience to this report.

TMS (Transcranial Magnetic Stimulation) Coil Market Dynamics

The report on the global TMS (Transcranial Magnetic Stimulation) Coil market includes a section that discusses various market dynamics that provide higher insight in the relationship and the impact of change these dynamics hold on the market functioning. These dynamics include the factors that are providing impetus to the market over the forthcoming years for growth and expansion. Alternatively, it also includes factors that are poised to challenge the market growth over the forecast period. These factors are expected to reveal certain hidden trends that aid in the better understanding of the market over the forecast period. Continue reading this report.

The Final Report Will Include the Impact of COVID -19 Analysis about the TMS (Transcranial Magnetic Stimulation) Coil Industry.

Get a free sample copy of this research report @ https://www.kandjmarketresearch.com/sample-request/409826

COVID-19 can affect the global market in 3 ways: by directly affecting the production and demand, by creating supply chain and market disturbance, and by its financial impact on enterprises and financial markets.

Key Players

The global TMS (Transcranial Magnetic Stimulation) Coil market report has provided a profiling of significant players that are impacting the trajectory of the market with their strategies for expansion and retaining of market share.

Key Segments Studied in the Global TMS (Transcranial Magnetic Stimulation) Coil Market:

Global TMS (Transcranial Magnetic Stimulation) Coil Market: Product Segment Analysis:

Global TMS (Transcranial Magnetic Stimulation) Coil Market: Application Segment Analysis:-

The Players mentioned in our report:-

Do You Have Any Query or Specific Requirement? Ask to Our Trade Expert @https://www.kandjmarketresearch.com/enquiry/409826

Global TMS (Transcranial Magnetic Stimulation) Coil Market: Regional Segment Analysis:-

Market Segmentation

The global TMS (Transcranial Magnetic Stimulation) Coil market has been studied for a detailed segmentation that is based on different aspects to provide insight into the functioning of the segmental market. This segmentation has enabled the researchers to study the relationship and impact of the growth chart witnessed by these singular segments on the comprehensive market growth rate. It has also enabled various stakeholders in the global TMS (Transcranial Magnetic Stimulation) Coil market to gain insights and make accurate relevant decisions. A regional analysis of the market has been conducted that is studied for the segments of USA, Europe, Japan, China, India, South East Asia.

Research Methodology

The global TMS (Transcranial Magnetic Stimulation) Coil market has been analyzed using Porters Five Force Model to gain precise insight in the true potential of the market growth. Further, a SWOT analysis of the market has aided in the revealing of different opportunities for expansion that are inculcated in the market environment.

Read More Detailed Information regarding TMS (Transcranial Magnetic Stimulation) Coil Industry with Covid-19 Updates @ https://www.kandjmarketresearch.com/reports/409826-world-tms-transcranial-magnetic-stimulation-coil-market-research-report-2025-covering-usa-europe-china-japan-india-and-etc

If you have any special requirements for the report, please let us know and we will offer you a customized report on separate regional or country-level reports.

About Us:

Kandjmarketresearch.com is part of the KnowledgeNJournals Research Firm which provides premium progressive market research reports, statistical surveying, analysis & forecast data for industries and governments from hundreds of publishers around the world. We have almost all top publishers reports in our collection to provide you with instant online access to the worlds most complete and fresh database on a Daily Basis. We are at KandJ Market Research are inspired to help our clients grow by providing appropriate business insight with our huge market intelligence source.

Contact us:

KandJ Market Research

(Part of KnowledgeNJournals Research)

(USA): +1 661 636 6162 | (IND): +91 932 580 2062

E-mail: [emailprotected]

Website: https://www.kandjmarketresearch.com

Read the original:

World TMS (Transcranial Magnetic Stimulation) Coil Market Industry: A Latest Research Report to Share Market Insights and Dynamics - Bulletin Line

Posted in Tms

TMS Webinar puts the spotlight on Offshore Oil and Gas – Latest Maritime & Shipping News Online – The Maritime Standard

CEO,Arya Offshore

Cdr. Sunil Dhulekar is the CEO of Arya Offshore which is a group company of J M Baxi Group. Headquartered in Mumbai the company plays host to practically every major player in the upstream sector in India. As a result of its vast experience , Arya Offshore Services brings to the table an unique array of dos and donts to all relevant entrants who need to navigate through the labyrinth of permissions, approvals and statutory compliances relating to operations in port, shipping, logistics and customs.

Arya Offshore Services today is the one of the largest service provider of its kind in India with over 300 trained personnel and with over 1500 contract personnel providing round the clock customized yet comprehensive services to the upstream oil and gas sector.

Cdr Sunil Dhulekar is an alumni of National Defence Academy. Commissioned in 1977 as an Executive Officer in the Indian Navy, his specialisation is Communications. He served on various class of ships ranging from Missile Corvettes upto the aircraft carrier INS Viraat. He retired from Indian Navy in 1999.

Joined Arya Offshore in 1999. Initially, he served in the Operations department of Arya Offshore handling major construction projects executed by clients like Hyundai Heavy Industries, J Ray McDermott, NPCC (Abu Dhabi), L & T (India) etc.

In addition to measuring up to the demanding marine, agency and support service requirements of the industry, Arya Offshore Services has operated multiple user shore cum supply bases in the west coast ports of Mumbai & Bhavnagar and in the east coast ports of Krishnapatnam, Paradip & Visakhapatnam and was instrumental in managing the Marine Shore Bases for British Gas in Mumbai, OAO Gazprom & Allseas Marine Contractors at Visakhapatnam on the East Coast of India. He was the Key Account Manager for a number of seismic companies like Western Geco (Schlumberger group), CGG Veritas, PGS etc. and drilling companies like Deep Water Drilling, ENSCO, Reliance Industries, etc.

He moved up the ladder and took over as Head Business Development in 2006 and subsequently stepped in as CEO of Arya Offshore in 2012.

As CEO of Arya Offshore Services, he has been closely associated in steering the company from a shipping agency to a full-fledged logistics solution provider with a customized range of service-offerings to the offshore and onshore Oil & Gas sector in India.

See the original post here:

TMS Webinar puts the spotlight on Offshore Oil and Gas - Latest Maritime & Shipping News Online - The Maritime Standard

Posted in Tms

Edited Transcript of GTMS.TO earnings conference call or presentation 5-Aug-20 2:00pm GMT – Yahoo Finance

Aug 6, 2020 (Thomson StreetEvents) -- Edited Transcript of Greenbrook TMS Inc earnings conference call or presentation Wednesday, August 5, 2020 at 2:00:00pm GMT

Greenbrook TMS Inc. - President, CEO & Director

Greenbrook TMS Inc. - CFO, Treasurer & Corporate Secretary

* David C. Martin

Clarus Securities Inc., Research Division - VP & Research Analyst of Growth and Innovation

Welcome to the Greenbrook TMS Inc. Second Quarter 2020 Results Conference Call and Webcast. (Operator Instructions) I would like to remind you that this conference call is being recorded today and is also being webcast on the company's website at http://www.greenbrooktms.com under the Investors section, Events. (Operator Instructions) Analysts and investors are reminded that any additional questions can be directed to the company at investorrelations@greenbrooktms.com.

This call contains forward-looking statements, which reflect the current expectations or beliefs of the company based on currently available information. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations are disclosed under the heading Risk Factors in the company's annual information form dated March 10, 2020, and in the company's MD&A for the period ended June 30, 2020, which are available on SEDAR and on the company's website. Any forward-looking statements speaks only as of the date on which it is made, and the company disclaims any intent or obligation to update any forward-looking statement unless required by law.

I would now like to turn the meeting over to Mr. Bill Leonard, President and Chief Executive Officer of Greenbrook TMS; and Erns Loubser, Chief Financial Officer. Go ahead, please, Mr. Leonard.

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [2]

Thank you, Lindsey, and thank you to everyone for joining our conference call and webcast today. We are very excited about our Q2 2020 results, which demonstrates our ability to navigate and grow during the challenging operating environment imposed by the COVID-19 pandemic. Overall, we were able to continue to grow our business even more than we expected, exceeding our previously disclosed revenue guidance while finding ways to continue to provide the highest quality services and to protect our patients, employees and physician partners.

Despite the challenging operating environment imposed by COVID-19 pandemic, we showed a resilient performance and sustained strong year-over-year revenue growth. With access to TMS therapy now more essential than ever, we have increased efforts to expand patient interactions virtually and the corresponding increased usage of these platforms by both patients and physicians contribute to this positive result. COVID-19 forced us to adapt and innovate. We expect our learning and experience through these times to provide valuable lessons and strong leverage as we continue to focus on expanding our base of clinics.

Quarterly consolidated revenue for Q2 2020 increased by 21% to $9.8 million as compared to Q2 2019, significantly exceeding our previously disclosed guidance. On a year-to-date 2020 basis, consolidated revenue increased by 44% to $21.2 million. Furthermore, Q2 2020 consolidated revenue of $9.8 million represented a decrease of only 14% as compared to Q1 2020, again, significantly exceeding our previously disclosed guidance.

We added 3 active TMS Centers during Q2 2020 with an additional 12 TMS Centers in development. This brings our total network to 125 Greenbrook Centers, which is an increase of 62% from Q2 2019. We're also particularly proud of our ability to reach new patients during this difficult time. In June, we established a record monthly high and new patient treatment starts, which supports a strong upward trend following the initial impact of COVID-19 and position us well for what we hope to be a strong Q3 and beyond.

And now for a more detailed review of the company's financial and operating performance, I will turn it over to our CFO, Erns Loubser.

--------------------------------------------------------------------------------

Erns Loubser, Greenbrook TMS Inc. - CFO, Treasurer & Corporate Secretary [3]

--------------------------------------------------------------------------------

Thank you, Bill. As Bill mentioned, despite the impact of COVID-19, consolidated quarterly revenue increased by 21% to $9.8 million in Q2 2020. On a year-to-date basis, consolidated revenue increased by 44% to $21.2 million. Furthermore, Q2 2020 consolidated revenue represented a decrease of only 14% as compared to Q1 2020. This positive result was primarily attributable to the increased efforts to provide greater access to patients virtually, through the expanded use of online platforms and focused marketing efforts on the safety and accessibility of our TMS Centers. The continued development of our TMS Center network by adding 3 active TMS Centers coupled with the Achieve TMS acquisition, also contributed to the strong growth. COVID-19 has increased demand for mental health services, including an increase in psychiatric visitors -- visits and depression and anxiety scripts, which we believe will continue to promote growth as operating conditions normalize.

As expected, same-region sales growth was negative 19% in Q2 2020, but remained positive at 2% on a year-to-date basis. The negative growth experienced in Q2 2020 was directly attributable to the impact of COVID-19. As operating conditions continue to normalize, we believe this metric will revert back to the pre-COVID-19 levels. Average revenue per treatment increased by 5% to $230 in Q2 2020 and by 5% to $234 during the year-to-date 2020 period. This increase was predominantly attributable to an increase in reimbursement rates from certain players with which we've had long-standing relationships in our established regions, and its expansion to more favorable reimbursement jurisdictions.

Moving to regional operating income. In line with our expectations, we incurred a regional operating loss for Q2 2020 of $200,000 as compared to regional operating income of $1 million in Q2 2019. Regional operating income decreased 68% to $500,000 during the year-to-date period 2020. This is from a prior -- this is attributable to a reduction in patient treatments during the period as a result of COVID-19. The regional operating income margin was 2.4% in year-to-date 2020 compared to 11.1% year-to-date 2019, again, due to the impact of COVID-19. Year-over-year corporate -- aggregate corporate costs increased by only 9% to $3.1 million for Q2 2020 and by 35% to $7 million on a year-to-date basis 2020. Quarter-over-quarter aggregate corporate costs, however, decreased by 19% or $750,000 compared to Q1 2020, really illustrating the success of our cost mitigation strategies.

The modest year-over-year increase in corporate G&A and decrease quarter-over-quarter, respectively, is a result of the investment in our business infrastructure and increased staffing of our shared services function in fiscal 2019, coupled with the Achieve TMS acquisition, again, offset significantly by disciplined measures implemented to control costs as a result of COVID-19.

As anticipated, the Q2 2020 and year-to-date 2020 aggregate corporate costs growth rate has decreased significantly as compared to the fiscal 2019, as we continue to scale into our centralized business infrastructure. This is further highlighted by the growth in revenue eclipsing the growth rate in aggregate corporate cost in both Q2 2020 and on a year-to-date 2022 basis. The loss for the period increased predominantly as a result for the earnout -- of the earnout payable to the sellers of Achieve TMS, which demonstrates the strong performance even during these challenging times by that business.

From a balance sheet perspective, accounts receivable increased by 0 -- by $800,000 to $10.9 million in Q2 2020 compared to Q4 2019 and decreased by $100,000 compared to Q1 2020. The company has already started to realize the benefits of the recent enhancements made to the billing and reimbursement system. This is despite the continued number of new TMS Centers with effects of payer contracting and billing system setup impacts to normal cash conversion cycle. And slightly slower reimbursement time lines experienced from payers due to the disruption caused by COVID-19. We expect accounts receivable to continue to stabilize throughout fiscal 2020.

As of Q2 2020, we had approximately $13.6 million in cash on hand, including an unsecured loan of approximately $3.1 million under the United States Paycheck Protection Program received during the quarter. We also completed a public offering of common shares for an aggregate gross proceeds of approximately CAD 15 million during the quarter. The company is using the net proceeds from the offering to fund operating activities and for other working capital and general corporate purposes, effectively strengthening our balance sheet in this current uncertain economic environment.

Moving to our core operating metrics. As of the end of Q2 2020, the total number of TMS Centers increased by 62% to 125 from 77 a year ago. Of the 125, currently, 113 centers are active and contributing to revenue. The number of consultations performed increased by 7% to 2,075 compared to Q2 2019. We increased the number of TMS treatments performed by 16% to 42,581 over Q2 2019. Patient starts increased by 22% to 1,218 compared to Q2 2019.

Our forward-looking indicators were all skewed down as a result of COVID-19 experienced during the quarter. As Bill mentioned earlier, however, we have seen a positive sentiment towards the end of the quarter, established a record monthly high in new patient start in June, which supports a strong upward trend and which we believe will position us well for the next quarter and beyond.

Back to you, Bill.

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [4]

--------------------------------------------------------------------------------

Thanks, Erns. As we mentioned earlier, we have demonstrated our ability to navigate and grow during the challenging operating environment imposed by COVID-19. Overall, we were able to exceed previously disclosed revenue guidance while continuing to provide the highest quality services and protecting our patient, employees and physician partners. We are particularly proud of our ability to reach new patients during this difficult time, and I am confident that our business will emerge even stronger as market conditions continue to normalize. The need for mental health support is an all-time high, and despite a slowdown in development activity, our development pipeline is stronger than ever and prime for expansion when market conditions allow. We have now treated over 13,000 patients with over 460,000 treatments performed. We are closing in on 0.5 million TMS therapy treatments, a significant positive impact on the lives of so many patients suffering from depression. We look forward to keeping you updated on the progress of the company throughout 2020.

Thank you for your time today. And with that, Lindsey, we will now take questions.

================================================================================

Questions and Answers

--------------------------------------------------------------------------------

Operator [1]

--------------------------------------------------------------------------------

(Operator Instructions) Our first question comes from the line of David Newman with Desjardins.

--------------------------------------------------------------------------------

David Francis Newman, Desjardins Securities Inc., Research Division - Analyst [2]

--------------------------------------------------------------------------------

Solid results and the trends look positive. So congratulations. I just want to get a little bit more attribution though around your outlook overall. So if you had to go month by month, in terms of patient volumes, revenues, new patient starts and some of the metrics that you guys measure. How did July shape up? And how did June shape up? And how did this kind of trend month-by-month through the quarter? Just so we get a better sense of your optimism for the third quarter, which obviously is looking pretty decent.

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [3]

--------------------------------------------------------------------------------

Yes, great question, David. I think from our perspective, when Q2 started, the initial impact of the pandemic was felt late March and then into the start of Q2 in April. From that point, we did several key items operationally that really helped us start to trend up. I think the first thing we did was really from a marketing perspective was to really get the message out on what shelter-in-place and stay-at-home government mandate meant. We did a great job with utilizing platforms such as TV and news radio to make sure patients understood the need for care of their mental health indications. That was the first thing. Allowing us to utilize the platform virtually really created patients the opportunity to get to us without having to have multiple trips to the center. And then really, we start to see a significant impact and rise in our treatments and new patient starts from really May and then into a record-breaking June. Obviously, I can't speak a lot about July, but I will tell you that I don't believe June will be our forever high watermark for the company for the year.

--------------------------------------------------------------------------------

David Francis Newman, Desjardins Securities Inc., Research Division - Analyst [4]

--------------------------------------------------------------------------------

Okay. And do you think you -- as you look out, do you think you could -- it sounds like you could, but I just want to hear your thoughts on it. But do you think you could exceed pre COVID level run rates?

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [5]

--------------------------------------------------------------------------------

Yes. I mean I continue to see positive trends. I think we are still in the midst of the pandemic, with hotspots popping up throughout the U.S. With that said, there's a different sentiment right now. I think patients were really confused early on the whole government mandates of stay-at-home and shelter-in-place. I think now you're seeing an increase in depression scripts written, you're seeing an increase in psychiatric visits. We've seen numbers of 20% to 30% of new scripts written, which really builds a pipeline for us in the future months ahead. So obviously, I do think the company will continue to grow, as we stated earlier. I think we are in a great position as an organization to take advantage of, unfortunately, the growth in mental health needs. So we feel really confident about the position we're in and expect to see growth in the months to come.

--------------------------------------------------------------------------------

David Francis Newman, Desjardins Securities Inc., Research Division - Analyst [6]

--------------------------------------------------------------------------------

All right, Bill. And then Bill, if you look out, I think your target -- initial target was like 140 centers by the end of this year. And you're not about far off, to be honest. And you've got about 18 months of capital for OpEx and CapEx. I mean how are you thinking about center expansion again? If you're seeing this kind of activity level. So what are you guys thinking in terms of that, in terms of expansion?

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [7]

--------------------------------------------------------------------------------

Yes. We are still focused on being a growth company. We are really kind of making sure that the trends continue to kind of move upwards. And as far as growth is concerned, like I said earlier, our pipeline has gotten better. One thing COVID did do was create a really strong pipeline for us. We continue to explore opportunities and at the right time, we'll kind of get back on the development train, which we hope to be late this year into Q1.

--------------------------------------------------------------------------------

David Francis Newman, Desjardins Securities Inc., Research Division - Analyst [8]

--------------------------------------------------------------------------------

Very good. And the last one for me, guys. Just on the cost cutting efforts, obviously, you did a lot of good things here in terms of your ability to cut costs, including furloughing some employees which are now coming back. And any of the savings that you're -- that you might believe could become more permanent? Often, these are opportunities to come along where -- I mean that COVID is not really an opportunity, but it does allow you to sort of look in the mirror and kind of look at your cost structure and find inefficiencies, and you did cite that you're around USD 1.2 million in discretionary expenses realized. I assume that's an annualized number towards your $2 million target. But anything that could be -- as we're looking to sort of forecasting our cost structure going out, any that's going to be more permanent in nature?

--------------------------------------------------------------------------------

Erns Loubser, Greenbrook TMS Inc. - CFO, Treasurer & Corporate Secretary [9]

--------------------------------------------------------------------------------

I think we certainly, as we mentioned, what COVID-19 did, it forced us to innovate. And also, as you mentioned, forced us to look at kind of our cost structure and the optimal cost structure. So I think there's certainly lessons learned how we managed to fairly rapidly take costs out of the cost structure from Q1 to Q2, a $750,000 reduction. So I think there is opportunity and some lessons learned that we can rationalize that and learn going forward as it relates to, for instance, marketing expenses to keep the business even leaner than it was before.

--------------------------------------------------------------------------------

David Francis Newman, Desjardins Securities Inc., Research Division - Analyst [10]

--------------------------------------------------------------------------------

And, Erns. Was that -- was the $750,000, was that actually out of the income statement? Or is that an annualized number?

--------------------------------------------------------------------------------

Erns Loubser, Greenbrook TMS Inc. - CFO, Treasurer & Corporate Secretary [11]

--------------------------------------------------------------------------------

That was actually -- so we had about $3.8 million in corporate G&A in Q1, and we came in about a $3.1 million in -- just below $3.1 million in Q2. So that was actual cost cuts based on kind of our Q1 run rate to our Q2.

--------------------------------------------------------------------------------

Operator [12]

--------------------------------------------------------------------------------

Our next question comes from the line of Noel Atkinson with Clarus Securities.

--------------------------------------------------------------------------------

Noel John Atkinson, Clarus Securities Inc., Research Division - VP & Research Analyst of Growth and Innovation [13]

--------------------------------------------------------------------------------

Well done in Q2. I wanted to get your insight about Neuronetics. So they've announced recently some significant improvements in TMS therapy eligibility with several major insurers. And I just wanted to see how you think that flows through to hopefully benefiting Greenbrook?

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [14]

--------------------------------------------------------------------------------

Yes. We appreciate and applaud the work Neuronetics did to continue to expand accessibility for TMS therapy. As it relates to their announcement yesterday, to me, what I think you're seeing now is the momentum driving as with TMS therapy is close to first-line treatment as possible when you're getting down to 1 to 2 failed cycles of med, compared to when we started, where in 2013, '17, it was 4 to 6 cycles of meds. So I think now that the payers are seeing the results of TMS therapy and the need to support depression modalities, I think you're seeing positive movement. With that said, to me, what I loved about it was the fact that demographically, it opens up the opportunity for us to treat younger patients. Some of the patients in that 18 to 21 range, 22, 23, have not been on 4 or 5 cycles of meds yet. They've only been on 1 or 2, so it allows you to get to that demographic, that younger patient population sooner as opposed to later. There is a lag period. I think, for every 1 or 2 trials you make, it's probably a 6th month lag. So I do think it helps increase the pipeline and expand the demographics late fall -- late winter, early spring for Greenbrook. And we're in a great position to take advantage of it, not only with our footprint, but with our growth. And obviously, we have great doctors and a great patient experience.

--------------------------------------------------------------------------------

Noel John Atkinson, Clarus Securities Inc., Research Division - VP & Research Analyst of Growth and Innovation [15]

--------------------------------------------------------------------------------

Okay. Great. This might have been asked already, I apologize, I had to step off for a sec. But are you negotiating with any of your landlords in terms of rent forbearance or deferrals or anything like that?

--------------------------------------------------------------------------------

Bill Leonard, Greenbrook TMS Inc. - President, CEO & Director [16]

--------------------------------------------------------------------------------

I wouldn't say we're negotiating because unlike some businesses, we actually have been open and seeing patients. We have not closed any of our centers down. So our patients are actively coming to our centers on a day-to-day basis. So it would be difficult for us to negotiate kind of abatement when we are still actively using those centers, which is a good thing as we stayed open during this pandemic.

--------------------------------------------------------------------------------

Noel John Atkinson, Clarus Securities Inc., Research Division - VP & Research Analyst of Growth and Innovation [17]

Original post:

Edited Transcript of GTMS.TO earnings conference call or presentation 5-Aug-20 2:00pm GMT - Yahoo Finance

Posted in Tms

Rivers on ancient Mars may have flowed beneath sheets of ice – Astronomy Magazine

The evidence that water once existed on Mars is unmistakable: The planet is covered in valleys that appear carved by flowing water. For decades, these epic ravines and branching riverbeds beckoned planetary scientists to imagine a 3.5-billion-year-old world that was both warm and wet, covered with lakes and rivers possibly hosting an environment conducive to life.

But new research suggests Mars might not have been the balmy paradise scientists once envisioned. Now, the evidence seems to suggest that rivers may not have covered its surface, but instead flowed deep under large sheets of ice.

To come to this conclusion, the researchers performed a statistical analysis of the shapes and patterns of 66 networks of valleys on Mars, which are composed of over 10,000 individual valleys. They then compared these to similar features on Earth.

They found that 14 of the martian sites appeared to have characteristics reminiscent of above-ground rivers. But 31 seemed to be carved out by either glacial or subglacial meltwater, more like terrain found near former glaciers on Earth.

See the original post here:

Rivers on ancient Mars may have flowed beneath sheets of ice - Astronomy Magazine

Move over, SpaceX Amazon is sending its own satellites into orbit – Salon

Astronomers were already concerned about SpaceX's plan to put 25,000 satellites in orbit. Andas of July 30, there's yet another reason for astronomers to believe that ground-based observational astronomy is about to become much more difficult: Amazon's Project Kuiper.

On Friday,news broke thatthe Federal Communications Commission approved Amazon's plans for its ambitious Kuiper constellation, which includes sending 3,236 satellites into three different altitudes in orbit.

The FCC's approval is a big regulatory stepand gives Amazon permission to move forward with the launch when they're ready. The satellites are part of Amazon's effort to provide satellite-based internet to everyone in the United States, an endeavor that's been positioned as havinga charitable and community-oriented mission.

"This investment will create jobs and infrastructure around the United States, build and scale our ground network, accelerate satellite testing and manufacturing, and let us deliver an affordable customer terminal that will make fast, reliable broadband accessible to communities around the world," Amazon stated in a blog post.

But many astronomers who depend on a clear sky from Earth to observe the universe, are wondering at what cost? Indeed, the more satellites in Earth's orbit, the more difficult it will be for astronomers to make accurate and unobstructed observations. Alexandre Lazarian, a professor of Astronomy at the University of Wisconsin - Madison, told Salon he believes the case of Amazon's commercial satellites " is one of many that hinders our exploration of the universe."

"I believe that some aspects of the civilization progress makes the work of observers more difficult," Lazarian said. "This includes light pollution, radio noise and also satellites."

On the other hand, Lazarian said that technological progress is opening up new horizons for astronomy.

Avi Loeb, chair of Harvard's astronomy department, told Salon via email that astronomers have long escaped light pollution by placing their telescopes far from cities. However, new communication satellites like Amazon's "will reflect sunlight and create a city of lights in the sky that no telescope on Earth can escape."

"The biggest impact will be on telescopes that survey large areas of the sky on a routine basis, such as the Vera Rubin Observatory that will see its first light in the coming year and is planned to conduct the extensive LSST survey, covering the southern sky every few days in search for transient events," Loeb told Salon. "The satellite constellations will leave streaks of bright on the CCD detectors of the observatory, making it difficult to separate real astronomical sources from their bright contaminating light."

In May, the Vera Rubin Observatory released a statement of concern regarding the launch of SpaceX satellites, and the plans of other companies like Amazon.

"The Vera C. Rubin Observatory science community is concerned about the increasing deployment of communications satellite constellations which, if unchecked, could jeopardize the discoveries anticipated from Rubin Observatory when science operations begin in 2022," the statement read. "Because Rubin Observatory is uniquely impacted by these satellite constellations, its science team is taking an active role in pursuing mitigation strategies to reduce the impact of the satellites on Rubin Observatory science."

Indeed, such efforts to send internet-based satellites have already begun. In late May 2019, SpaceX launched the first 60 of itsof 42,000 communications satellites for the planned Starlink constellation. Since then, Elon Musk's company has launched several more groups of 60 satellites. While satellites aren't necessarily a new problem for astronomers, the brightness of the SpaceX-launched satellites have been a big concern for astronomers.

In January 2020, a study published in the journal Astronomy & Astrophysics analyzed the potential impact of commercial satellites like those by SpaceX and Amazon and found that large telescopes will likely be "moderately affected."

"The results suggest that large telescopes like ESO's VLT and upcoming ELT will only be moderately affected, although some science cases may require the implementation of mitigation measures, such as scheduling of the observations or interruption of the exposures to allow a satellite to cross the field of view," the study concluded.

Amazon said it will invest more than $10 billion in Project Kuiper in the company's statement. While there are no specific launch dates yet, under the FCC's approval the company must launch half of the constellation by 2026 to keep its FCC license, and the remaining satellites by 2029.

Read the original post:

Move over, SpaceX Amazon is sending its own satellites into orbit - Salon

Amateur Astronomers Find a Saturn-Sized Planet in The Habitable Zone of a Distant Star – ScienceAlert

Exoplanets have been a particularly hot topic of late.

More than 4,000 of them have been discovered since thefirstin 1995. Now one more can potentially be added to the list. This one is orbiting Gliese 3470, a red dwarf star located in the constellation Cancer. What makes this discovery particularly interesting is that this planet wasn't discovered by any professional astronomers using high tech equipment like theKepler Space Telescope. It was found entirely by amateurs.

Not just any amateurs though they are part of an effort organized by Alberto Caballero of theThe Exoplanets Channelon Youtube.

The group is called theHabitable Exoplanet Hunting Project(HEHP) and bills itself as "the first international program coordinated by amateur astronomers to search for habitable exoplanets."

The group "includes more than 30 amateur and professional observatories located in more than 10 countries across 5 continents". The group coordinates efforts across all these observatories by observing the same star concurrently for significant lengths of time.

In the case of the new planet, which being called Gliese 3470c, most of the observational data came from an amateur astronomer named Phillip Scott located in Kiowa, Oklahoma, about 2 hours southeast of Oklahoma City.

The observations were done using his own personal 12.5 inch telescope, that he built a observatory in his backyard to house. They were carried out between the months of December 2019 and May 2020.

The data collected during that period was analyzed using a technique known astransit photometry, which watches for changes in a star's brightness. The team observed three transits of the potential planet, which they say may have an orbital period of 66 days.

Given the size of Gliese 3470, that would put the planet around the point of 'Earth's Equivalent Radiation', making it possible that the planet resides in the habitable zone of the star.

The planet itself is too big to be an Earth analogue though, coming in at more than 9.2 times the radius of Earth, placing it more akin to the size of Saturn. The team also can't rule out that the planet might actually have a faster orbit that they proposed, as data was not available for some other times when it might have been transiting if the orbital period was shorter.

The planet will indeed need further confirmation, both of its orbital period and also of its existence in general. As is common with exoplanet discoveries, the HEHP team published their findings, along with a Google drive link to theirdata, and are actively encouraging other astronomers to observe Gliese 3470 to confirm their new planet.

Let's hope that their discovery is not only confirmed, but also inspires more amateur astronomers to pick up the torch of searching for habitable exoplanets.

If you want to join the organization in their efforts, you can find more detailshere.

This article was originally published by Universe Today. Read the original article.

Read the rest here:

Amateur Astronomers Find a Saturn-Sized Planet in The Habitable Zone of a Distant Star - ScienceAlert

Astronomy Apps Market Expected to Witness the Highest Growth 2025 – AlgosOnline

Recently, Market Study Report, LLC, added a research on the ' Astronomy Apps market' which encompasses significant inputs with respect to market share, market size, regional landscape, contributing players, and revenue projection of this industry vertical. The report also educates investors regarding the existing tends, prime challenges, and current expansion strategies applied by the key organizations that constitute the hyperactive competitive gamut of this business sphere.

Request a sample Report of Astronomy Apps Market at:https://www.marketstudyreport.com/request-a-sample/2586493?utm_source=algosonline.com&utm_medium=Ram

The Astronomy Apps market report predicts this business space to accrue quite some modest proceeds by the end of the estimated timeline. Inherently, the report is inclusive of details pertaining to the market dynamics such as the numerous driving forces responsible for impacting the outlook of this industry as well as the myriad risks that this sphere is defined by, not to mention, the innumerable growth opportunities prevalent in the marketplace in question.

Questions which the research study on Astronomy Apps market answers with respect to the competitive hierarchy of the industry:

Questions which the research study on Astronomy Apps market answers with respect to the regional hierarchy of the industry:

Questions which the research study on Astronomy Apps market answers with respect to the segmentation of the industry:

Ask for Discount on Astronomy Apps Market Report at:https://www.marketstudyreport.com/check-for-discount/2586493?utm_source=algosonline.com&utm_medium=Ram

In essence, it would be apt to quote that the research study on the Astronomy Apps market comprises an expansive analysis of this industry space which focuses not just on the geographical scope of this market but also on a plethora of other deliverables such as the market share, revenue estimate, market concentration rate, sales volume, and the market competition trends. Also presented in the report are details with reference to the sales channels that are adopted by myriad manufacturers in a bid to ensure that an accurate method of marketing the product is chosen. Information regarding the contribution of traders as well as distributors in the supply chain are also enlisted in the study.

For More Details On this Report: https://www.marketstudyreport.com/reports/global-astronomy-apps-market-2020-by-company-regions-type-and-application-forecast-to-2025

Read More Reports On: https://www.marketwatch.com/press-release/238-growth-for-3d-sensor-market-size-to-reach-22660-million-usd-by-2026-2020-08-05?tesla=y

Read More Reports On: https://www.marketwatch.com/press-release/industrial-edi-ultrapure-water-system-market-global-industry-analysis-segments-top-key-players-drivers-and-trends-to-2026-2020-08-04?tesla=y

Read More Reports On: https://www.marketwatch.com/press-release/breast-implants-market-trends-share-industry-size-opportunities-analysis-and-forecast-by-2027-2020-08-03?tesla=y

Read More Reports On: https://www.marketwatch.com/press-release/laboratory-filtration-market-size-opportunities-share-analysis-up-to-2027-2020-07-30

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See the original post here:

Astronomy Apps Market Expected to Witness the Highest Growth 2025 - AlgosOnline

Saturn-Sized Exoplanet Discovered by the Gravitational Wobble in the Small, Cool Star It Orbits – SciTechDaily

Illustration shows how the stars motion around the center of mass between it and the planet causes a wobble in its motion through space. The VLBAs ability to detect this minuscule effect revealed the presence of the planet. Credit: Bill Saxton, NRAO/AUI/NSF

Using the supersharp radio vision of the National Science Foundations continent-wide Very Long Baseline Array (VLBA), astronomers have discovered a Saturn-sized planet closely orbiting a small, cool star 35 light-years from Earth. This is the first discovery of an extrasolar planet with a radio telescope using a technique that requires extremely precise measurements of a stars position in the sky, and only the second planet discovery for that technique and for radio telescopes.

The technique has long been known, but has proven difficult to use. It involves tracking the stars actual motion in space, then detecting a minuscule wobble in that motion caused by the gravitational effect of the planet. The star and the planet orbit a location that represents the center of mass for both combined. The planet is revealed indirectly if that location, called the barycenter, is far enough from the stars center to cause a wobble detectable by a telescope.

Side-by-side animations of the star and planet orbiting their common center of gravity (barycenter), and of the pair moving through space as they orbit, creating the stars wobble that revealed the planet. Credit: Bill Saxton, NRAO/AUI/NSF

This technique, called the astrometric technique, is expected to be particularly good for detecting Jupiter-like planets in orbits distant from the star. This is because when a massive planet orbits a star, the wobble produced in the star increases with a larger separation between the planet and the star, and at a given distance from the star, the more massive the planet, the larger the wobble produced.

Starting in June of 2018 and continuing for a year and a half, the astronomers tracked a star called TVLM 51346546, a cool dwarf with less than a tenth the mass of our Sun. In addition, they used data from nine previous VLBA observations of the star between March 2010 and August 2011.

Artists conception of dwarf star TVLM-513-46546 and its newly-discovered planetary companion. Credit: Luis A. Curiel Ramirez

Extensive analysis of the data from those time periods revealed a telltale wobble in the stars motion indicating the presence of a planet comparable in mass to Saturn, orbiting the star once every 221 days. This planet is closer to the star than Mercury is to the Sun.

Small, cool stars like TVLM 51346546 are the most numerous stellar type in our Milky Way Galaxy, and many of them have been found to have smaller planets, comparable to Earth and Mars.

Artists conception of dwarf star TVLM-513-46546 and its newly-discovered planetary companion. Credit: Luis A. Curiel Ramirez

Giant planets, like Jupiter and Saturn, are expected to be rare around small stars like this one, and the astrometric technique is best at finding Jupiter-like planets in wide orbits, so we were surprised to find a lower mass, Saturn-like planet in a relatively compact orbit. We expected to find a more massive planet, similar to Jupiter, in a wider orbit, said Salvador Curiel, of the National Autonomous University of Mexico. Detecting the orbital motions of this sub-Jupiter mass planetary companion in such a compact orbit was a great challenge, he added.

More than 4,200 planets have been discovered orbiting stars other than the Sun, but the planet around TVLM 51346546 is only the second to be found using the astrometric technique. Another, very successful method, called the radial velocity technique, also relies on the gravitational effect of the planet upon the star. That technique detects the slight acceleration of the star, either toward or away from Earth, caused by the stars motion around the barycenter.

The Very Long Baseline Array is a continent-wide radio telescope system spanning the distance from Hawaii in the Pacific to St. Croix in the Caribbean. It provides astronomers with extremely high resolving power, the ability to see fine detail. Credit: J. Hellermann, NRAO/AUI/NSF

Our method complements the radial velocity method which is more sensitive to planets orbiting in close orbits, while ours is more sensitive to massive planets in orbits further away from the star, said Gisela Ortiz-Leon of the Max Planck Institute for Radio Astronomy in Germany. Indeed, these other techniques have found only a few planets with characteristics such as planet mass, orbital size, and host star mass, similar to the planet we found. We believe that the VLBA, and the astrometry technique in general, could reveal many more similar planets.

A third technique, called the transit method, also very successful, detects the slight dimming of the stars light when a planet passes in front of it, as seen from Earth.

Very Long Baseline Array (VLBA) astrometry detected a wobble in the proper motion of a small star caused by the gravitational effect of a Saturn-sized exoplanet. First radio discovery of an exoplanet by this technique. Credit: NRAO/AUI/NSF

The astrometric method has been successful for detecting nearby binary star systems, and was recognized as early as the 19th Century as a potential means of discovering extrasolar planets. Over the years, a number of such discoveries were announced, then failed to survive further scrutiny. The difficulty has been that the stellar wobble produced by a planet is so small when seen from Earth that it requires extraordinary precision in the positional measurements.

The VLBA, with antennas separated by as much as 5,000 miles, provided us with the great resolving power and extremely high precision needed for this discovery, said Amy Mioduszewski, of the National Radio Astronomy Observatory. In addition, improvements that have been made to the VLBAs sensitivity gave us the data quality that made it possible to do this work now, she added.

Curiel, Ortiz-Leon, Mioduszewski, and Rosa Torres of the University of Guadalajara in Mexico, reported their findings in the Astronomical Journal.

Reference: An Astrometric Planetary Companion Candidate to the M9 Dwarf TVLM 51346546 by Salvador Curiel, Gisela N. Ortiz-Len, Amy J. Mioduszewski and Rosa M. Torres, 4 August 2020, Astronomical Journal.DOI: 10.3847/1538-3881/ab9e6e

The National Radio Astronomy Observatory is a facility of the National Science Foundation, operated under cooperative agreement by Associated Universities, Inc.

The rest is here:

Saturn-Sized Exoplanet Discovered by the Gravitational Wobble in the Small, Cool Star It Orbits - SciTechDaily

Song Sung This Ascension is Ours – musicOMH.com

(Night Time Stories) UK release date: 31 July 2020

The success of The Ascension Is Ours is ultimately down to its exquisitely rendered sound design the songs, with their ethereal haze and retro-futurist vibe, are a blend of Broadcast, The Shangri-Las, and, well, all of the bands on the Killing Eve soundtrack. All of these are tried and tested flavours, and while these are ultimately what make the album a triumph, theyre also what would make it a difficult listen for people not already familiar with this type of sound. See, most of the songs are constructed of the same basic formula, and all of the tracks seem to run a little long.

The highlights of the album are the fantastic TellingTales, with its superb chorus and hazy, woozy atmospherics, and Testimony Of Tears, with its muscular bass and gradually increasing tension, are genuinely thrilling pieces. The Minds Eye is another standout, and it sounds like a forgotten girl-group 7 playing in The Jesus & Mary Chains distorted wonderland (or, put simply, it sounds like The Raveonettes). The other songs on the album largely use the same palette, and draw from the same type of sounds but theres a lot to be said for consistency. Many of the bands that Song Sung draw from made similarly stylistically consistent debut albums (have you heard Psychocandy?), and ultimately it will be this level of one-notedness that means you love the album or are bored by it.

Many of the bands that have ploughed similar ground have had success (Vanishing Twin, Exploded View, Jane Weaver, Le Volume Courbe), because there feels like theres more variety in their songwriting. But this is a debut album, and there is a lot of potential here. If youre a fan of any of those bands, then this should be an immediate listen, but if not, this is a harder sell. Enter with an open mind (and a spare hour), and youll have a good time.

Related articles

Originally posted here:

Song Sung This Ascension is Ours - musicOMH.com

Starting Friday in the 60s, ending in the 90s – WBRZ

After starting the day in the 60s, the intense humidity will hold off for the afternoon. Check out that 6 am temperature!

THE FORECAST:

Today and Tonight:Sunny skies and mild humidity in August. Enjoy it while it lasts! Temperatures will be heating to near 94 degrees, but low dew points will prevent heat index values from entering the triple digits. A 10% chance of rain today is for areas near the coast. A few showers could creep up into parts of St. James, Assumption, and southern Ascension Parishes. Skies will clear overnight with lows near 73 degrees.

Up Next:Intense humidity will begin to move back in during the day tomorrow. Only a few showers are expected along the coast and south of Baton Rouge. Saturday high temperatures will be near 94 and lows near 75. Starting on Sunday, rain chances will go up to 20-30% and stay that way into next week. The weekend will still have plenty of sun. Many places will be able to dodge the rain altogether. If you need an hour-by-hour rain update, download our mobile weather app! (Links down below.) High temperatures will remain in the low 90s.

The Tropics:No active advisories.

THE EXPLANATION:

The trough over the central US continues to promote northerly flow in our area. Throughout the day today, this will completely weaken, and our flow will shift to southerly. Southerly flow will bring Gulf moisture with it and we can say goodbye to low humidity. A ridging pattern is developing over the southern US. This is crank up the heat and moisture over the weekend and bring in the chance of afternoon showers every day starting on Saturday. Moisture will build through the week and rain chances will climb to near 40% by Tuesday.

-Marisa

The WBRZ Weather Team is here for you, on every platform. Your weather updates can be found on News 2, wbrz.com, and the WBRZ WX App on yourAppleorAndroiddevice. Follow WBRZ Weather onFacebookandTwitterfor even more weather updates while you are on the go.

See original here:

Starting Friday in the 60s, ending in the 90s - WBRZ

Tesla makes tiny change to Model Y that will save owners some headaches – Electrek

Tesla has made a tiny change to Model Y that will save owners some headaches by helping people get out of the car the right way.

On Model 3 and Model Y, Tesla didnt install regular door handles with latches inside the vehicles.

Instead, Tesla installed an electronic button to release the door and manual releases on the front doors.

But the latter are only intended to be used in the unlikely event that the vehicle loses power.

Tesla writes in the owners manual:

Manual door releases are designed to be used only in situations when Model 3 has no power. Whenever Model 3 has power, use the button located at the top of the interior door handle

The problem is that some people more naturally go for the manual release (right) instead of the electronic release (left):

It meant that Tesla owners often had to explain passengers how to properly get out of their vehicle.

The issue is that Teslas vehicles have a frameless door design meaning that the window has to come down a little bit before opening the door. The electronic release doesnt allow you to open the door until thats completed, which only takes a second.

But with the manual release, someone could right away push the door open, which could cause an issue.

Thats why in our post on the Top 15 Tesla accessories you must have, we have been recommending a sticker to put on the electronic release button that indicates its use better than a simple line.

Now it looks like Tesla has caught up to this issue.

Christian Bibay recently took delivery of a new Model Y and spotted a new clearer sign on the button. He posted a picture to a Model 3 Facebook group (hat tip to JZ):

The new design appears to be inspired by another aftermarket sticker that Tesla owners have been buying.

The feature is in new Model Y vehicles currently being delivered.

Its currently unclear if the change has also made it to new Model 3 vehicles coming off the line, but one would assume that it would be coming soon if it isnt already done.

FTC: We use income earning auto affiliate links. More.

Subscribe to Electrek on YouTube for exclusive videos and subscribe to the podcast.

Original post:

Tesla makes tiny change to Model Y that will save owners some headaches - Electrek

Tesla Is Limiting Supercharging To 120 kW In Europe, But Why? – InsideEVs

Tesla is proud to offer superchargers all over the US and also in Europe. In Portugal, it is the only electric car manufacturer widely accepted because it provides a fast-charging network that the country currently lacks. Yet, Tesla owners are complaining that they can't get more than 120 kW in most countries. They have asked Tesla for explanations and got none so far.

The reports of this speed limit come from Spain, UK, Portugal, Sweden, and most other countries in which the cars are sold. According to Tesla club members, some of them occasionally manage to pass that limit, while most are stuck with the 120 kW. Some are even more precise in the description: they say the cars can only achieve 117 kW, even when there is no other car charging.

According to club communication we had access to, people were concerned that Tesla could have nerfed the cars. Tests in other charging stations, such as Ionity's, showed the issue was really with superchargers.

These owners have tried to contact Tesla to understand the issue and got no official explanation for that until now. One fair demand they have is that Tesla could warn owners approaching any given supercharging station about any restrictions.

With the issue, some club members have developed theories for what is happening. Some believe Tesla decided to prevent superchargers from achieving the up to 150 kW of capacity due to the hot weather Europe is facing in many countries this year. Anyway, if that were really the case, any temperature spike in the past would have caused the same decrease in charging speed.

Considering slower charging sessions also cost more, another possibility is that the restriction has financial goals. The only party able to explain anything is Tesla. We'd ask it if the company replied to the press, but it doesn't. Will it at least tell owners and club members the reasons for the restrictions?

Have you felt your Tesla had its charging speed capped recently? If you have, please let us know more about it at contact@insideevs.com or through our Facebook page. It does not matter where you are: just let us know if you feel your supercharging network is also affected.

Read more:

Tesla Is Limiting Supercharging To 120 kW In Europe, But Why? - InsideEVs

GM Is Looking Pretty Jealously At Tesla And Nikola – Jalopnik

Photo: Getty Images (Getty Images)

In recent months, Teslas soaring stock price has seemingly boosted startup Nikola, which was once valued as high as $26 billion despite having no revenue. According to a new report, GM might want to try and get in on that investor hype.

That is in part because investors apparently dont believe legacy car companies like GM can pull off an electric car. Even though GM already has, and is working on more, that hasnt done much for its stock price, which is what GMs CEO Mary Barra and its board cares about. GM thinks its doingand has donequite a bit in the electric space and getting no love on Wall Street in return.

And so now, Bloomberg reports, GM has been deliberating over whether or not to spin off its electric-vehicle operations. That new company would have a different name, none of the baggage of GMs 111-year history, and, in theory, would also inspire more investment. In theory.

GM now is war-gaming the idea as the company ponders different ways to get credit for its EV plans, though a spinoff isnt actively being prepared, said the people, who asked not to be identified discussing internal deliberations.

[...]

The view within GM is that the startups attracting billions of dollars of investment have a fraction of the capabilities Barra touted back in February and March.

This would maybe look much like what Tesla did and what Nikola is trying to do, which is to take the new company public and fund research and development through new investment from Wall Street. Thats a strategy that Lordstown Motors and Fisker are also pursuing. And clearly also a flavor-of-the-month kind of thing, but you get the feeling that Tesla is a bit of unicorn in this regard. It somehow pulled it off after years of walking on a tightrope, something that maybe looks easier than it was now that there is so much money getting thrown around.

Read this article:

GM Is Looking Pretty Jealously At Tesla And Nikola - Jalopnik

Confused golden retriever wags its tail as Tesla-driving owner abandons it in park and races off – Metro.co.uk

A confused golden retriever thought he was going for walkies only for his cruel Tesla driving owner to dump him in a park and drive off (Pictures: Clark County Sheriffs Office)

Distressing surveillance camera footage captured the moment a confused golden retriever wagged its tail as its Tesla-driving owner dumped it in a park. The dog was abandoned at Vancouver Park just north of Portland, Oregon earlier this month.

Footage obtained by KOIN showed the pets female owner pull into a parking spot in her gray Tesla Model 3 which retails for a minimum $37,500. She gets out of the luxury electric car and opens the back door to let her dog out.

The animal wags its tail and looks at its owner in anticipation a walk around the beauty spot.

She then tricks the dog into thinking they are doing just that and walks it towards a wooded area, then dashes back to the car before the dog can follow her, and drives off without it.

To view this video please enable JavaScript, and consider upgrading to a webbrowser thatsupports HTML5video

Thankfully, the dog was rescued and is now being cared for by I Pawd It Forward animal shelter in Portland. The animal will be put up for adoption once shelter staff have confirmed it had not been stolen from anyone else who was looking for it.

Clark County Sheriffs Office is investigating the act of abandonment, and have appealed for anyone who recognizes the dog dumper to contact them.

Get in touch with our news team by emailing us atwebnews@metro.co.uk

For more stories like this,check our news page

The rest is here:

Confused golden retriever wags its tail as Tesla-driving owner abandons it in park and races off - Metro.co.uk

Why doctors and researchers need access to hydroxychloroquine | TheHill – The Hill

On July 6, a team of doctors from Henry Ford Hospital, supported by physicians from Baylor University Medical Center, submitted an urgent request to the Food and Drug Administration (FDA) to reauthorize use of hydroxychloroquine (HCQ) for early treatment of COVID-19. Since that day, more than 25,000 more Americans have died from the virus as COVID-19 continues to burn through communities across America. If the results of a recent Henry Ford Hospital study are accurate, at least half of these patients might have been saved by HCQ.

Since the pandemic from China first hit America with brute force early in March, it has become apparent to physicians that the medicine works best when as with any anti-infective agent it is given early in the course of the infection. Moreover, hospitalization can be avoided if treatment starts within the first day of symptoms.

While HCQ alone has been found by numerous studies to reduce mortality rates, severity of symptoms, and length of hospital stays, it also can be combined with zinc and either azithromycin or doxycycline, followed by corticosteroids (prednisone, dexamethasone), and in some cases anticoagulants all working together for improved outcomes. For each one of these drugs, there is both a good scientific rationale and either early clinical trials completed or planned with sufficient promise.

Of these drugs, only HCQ was singled out as a political football early in spring right after President TrumpDonald John TrumpJoe Arpaio loses bid for his old position as sheriff Trump brushes off view that Russia denigrating Biden: 'Nobody's been tougher on Russia than I have' Trump tees up executive orders on economy but won't sign yet MORE urged the medical community to consider HCQ. At the time, one of Trumps top medical advisers, Dr. Anthony FauciAnthony FauciOvernight Health Care: Trump to take executive action after coronavirus talks collapse | Vaccine official says he'd resign if pressured politically Fauci's DC neighbors put up 'thank you' signs in their yards Cuomo says New York schools can reopen in-person this fall MORE, stated that if a COVID-19 patient were under his care, he would use HCQ, preferably in a clinical trial protocol. Fauci, however, has since backed away from that statement and his opposition has become a rallying cry of the left-leaning mainstream medias Hydroxy Hysteria.

The politicization of HCQ is an ongoing tragedy. The Federal Emergency Management Agency (FEMA) has more than 60 million HCQ tablets sitting in its warehouses. Absent a new Emergency Use Authorization, FEMA cannot ship this valuable medicine for appropriate off-label treatment of COVID-19 patients. Nor can hospitals or clinics easily recruit patients for the kind of randomized clinical trials needed to ultimately settle the question of how HCQ might best be used in the fight against COVID-19. Should it be purely in early treatment, as a prophylactic for health care workers or senior home patients at risk, in outpatient versus hospital settings, or in other settings?

Positive HCQ studies have been dismissed in medical journal editorials as flawed because they were observational rather than randomized. The few randomized trials of HCQ reported to date have been a debacle because of the failure to distinguish clearly between early treatment (one to seven days after the onset of symptoms), when the medicine should work, versus later treatment, when it is unlikely to help. To make matters worse, in a classic statistical type two error, many of the preventive and early illness trials of HCQ changed primary endpoints, reduced sample sizes, and became unable to see the benefit of HCQ, if indeed it was there.

For example, the University of Minnesota, in a collaboration with other centers, published randomized prevention and early treatment trials. While both trials were stopped early and thereby had small samples, both made definitive claims that HCQ was not effective. However, careful review of their data shows just the opposite numerically (but not statistically significant) lower numbers of infections and hospitalizations in those who were randomized to HCQ.

Further clouding the issue, the National Institutes of Health opened an outpatient trial of HCQ and azithromycin in May but closed it in June, stating they could not recruit subjects into the study. This was a highly disingenuous claim, given the overwhelming numbers of COVID-19 patients desperate for treatment.

My own conclusion from a review of the literature is that HCQ has not failed the randomized trials, but researchers have failed HCQ. Many doctors who understand the science and the threats to validity in the HCQ literature continue to prescribe HCQ appropriately off-label to COVID-19 victims at home, in senior centers, and early in the hospital. The Association of American Physicians and Surgeons is suing the FDA for access to HCQ.

In thinking carefully about all the negative news that you may have heard about HCQ, keep in mind this drug has been used in the U.S. since 1955. It has a completely established safety record for lupus, rheumatoid arthritis, and malaria prevention and treatment. Prescribed under a physicians good judgment, it is unlikely to cause harm.

So how did HCQ become considered dangerous? The first false safety concerns arose early in the pandemic in reports that doctors prescribed HCQ not in an early treatment setting at the first sign of symptoms but rather in a late-stage setting to more severely ill patients in the hospital. This form of treatment bias that is, giving medicine to the sickest before death created a false association between HCQ and mortality. Unfortunately, the mainstream media picked up on these reports and did great damage by promulgating a false narrative without understanding the epidemiological underpinning of confounding by indication.

In what would be a death blow to public trust of HCQ, the prestigious Lancet journal published a massive worldwide study that purported to show excessive deaths in patients treated across six continents only to have the paper later retracted. The New England Journal of Medicine had a similar unprecedented retraction more evidence of HCQ becoming a political football in medical science. While the studies were fraudulent and discredited within a few weeks, the media coverage, and earlier flawed studies, led both the FDA and World Health Organization (WHO) to withdraw endorsements of the drug for COVID-19 treatment.

We now know, based on thelarge New York and Detroit experiences at Ford and Mt. Sinai hospitals, that HCQ is safe. To date, there has not been a single credible report that the medication increases the risk of death in COVID-19 patients when prescribed by competent physicians who understand its safety profile.

It is time for the FDA and state medical boards to support the use of HCQ in conjunction with other commonly used drugs steroids and antithrombotics against COVID-19, treated early at home to help avoid hospitalization and death. As President Trump has said, what have you got to lose by reinstating an Emergency Use Authorization? As to what might be gained, appropriate research and prescription (combined with other medications) could spare hundreds of thousands of hospitalizations and save tens of thousands of American lives.

Peter A. McCullough, MD, MPH, is vice chairman of medicine at Baylor University Medical Center and a professor of medicine at Texas A&M College of Medicine in Dallas. An internist, cardiologist and epidemiologist, he is the editor in chief of Cardiorenal Medicine and Reviews in Cardiovascular Medicine. He has authored over 500 cited works in the National Library of Medicine.

Read the original post:

Why doctors and researchers need access to hydroxychloroquine | TheHill - The Hill

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity…

FOSTER CITY, Calif.--(BUSINESS WIRE)--Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anticancer therapies.

The study will help determine to what extent Notable's technology platform has the ability to predict clinical responses in patients treated with standard of care therapies in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). In addition, the study explores how a patient's disease changes in response to specific therapies, and whether Notable can potentially combat resistance to therapy by finding new effective combinations on its platform.

The study will be conducted at Washington University School of Medicines Siteman Cancer Center. Notable is performing the ex vivo drug sensitivity tests in its laboratory in Foster City.

This is a very important validation study for Notable, said Hiroomi Tada, M.D., Ph.D., chief medical officer at Notable. It will provide a large dataset that will enable us to compare our ex vivo test results with patient outcomes, which we need to understand how well our assays work, and determine whether we need to improve the assays for certain classes of drugs to make the tests better. In addition, the study will provide us with insight into how AML and MDS change in response to treatment, identify potential new combination therapies and if patients are failing a therapy much earlier, allowing us to intervene sooner as resistance is emerging.

Medical oncologist John Welch, M.D., Ph.D., associate professor in the division of oncology at Washington University School of Medicine, said, It can be difficult to predict patients responses to chemotherapy, and we look forward to evaluating whether Notables platform has the potential to change the way clinicians approach cancer therapy for individual patients. This trial is intended to help determine the platforms accuracy and its value as a clinical care tool.

This is expected be a five-year study, though data from the first cohort could be available within 1218 months.

About Notable

Notable is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers. Notables testing platform combines machine learning, automation and high-throughput screening directly on patient samples to predict responses to potential therapies, and ultimately determine which therapies will be most effective for specific cancers. Notables functional precision medicine platform will advance drug development and enable pharmaceutical companies to get new therapies to patients faster. Learn more at notablelabs.com and follow us @notablelabs.

Go here to see the original:

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity...